The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.
Clinical trial NCT05947578 · COMPLETED
Trial details
- NCT number
- NCT05947578
- Sponsor
- Cellatoz Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-19
- Primary completion
- 2024-08-09
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.